Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases

Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases

Antibiotic failure is one of the most worrying health problems worldwide. We are currently facing an international crisis with several problematic facets: new antibiotics are no longer being discovered, resistance mechanisms are occurring in almost all clinical isolates of bacteria, and recurrent in...

Full description

Bibliographic Details
Main Authors:	Olga Pacios, Lucia Blasco, Inès Bleriot, Laura Fernandez-Garcia, Mónica González Bardanca, Antón Ambroa, María López, German Bou, Maria Tomás
Format:	Article
Language:	English
Published:	MDPI AG 2020-02-01
Series:	Antibiotics
Subjects:	anti-mdr strategies anti-persistent treatments drug repurposing
Online Access:	https://www.mdpi.com/2079-6382/9/2/65

Similar Items

Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
by: Marhiah C. Montoya, et al.
Published: (2018-12-01)

In vitro polymyxin activity against clinical multidrug-resistant fungi
by: Hanane Yousfi, et al.
Published: (2019-04-01)

Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia
by: Fanta Desissa, et al.
Published: (2018-04-01)

Viral Related Tools against SARS-CoV-2
by: Laura Fernandez-Garcia, et al.
Published: (2020-10-01)

Systematic Evaluation of Structure-Activity Relationships of the Riminophenazine Class and Discovery of a C2 Pyridylamino Series for the Treatment of Multidrug-Resistant Tuberculosis
by: Haihong Huang, et al.
Published: (2012-04-01)

Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met
by: Vivek Kumar Gupta, et al.
Published: (2017-01-01)

Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
by: Panagiota Papanagnou, et al.
Published: (2016-05-01)

Written Documents Analyzed as Nature-Inspired Processes: Persistence, Anti-Persistence, and Random Walks—We Remember, As Along Came Writing—T. Holopainen
by: Omar López-Ortega, et al.
Published: (2020-09-01)

Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library
by: Jie Feng, et al.
Published: (2015-09-01)

Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials
by: Sílvia A. Sousa, et al.
Published: (2021-08-01)

Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase
by: Christopher I. Ma, et al.
Published: (2021-03-01)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020-11-01)

Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance
by: Nirmala Tilija Pun, et al.
Published: (2021-05-01)

Identification of Anti-staphylococcal and Anti-biofilm Compounds by Repurposing the Medicines for Malaria Venture Pathogen Box
by: Vasundhra Bhandari, et al.
Published: (2018-10-01)

Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database
by: Lachaine Jean, et al.
Published: (2013-01-01)

Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018
by: Mariana Buziashvili, et al.
Published: (2021-01-01)

Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
by: Andrea Miró-Canturri, et al.
Published: (2021-05-01)

Tedizolid Activity Against Clinical Mycobacterium abscessus Complex Isolates—An in vitro Characterization Study
by: Ying Wei Tang, et al.
Published: (2018-09-01)

RepTB: a gene ontology based drug repurposing approach for tuberculosis
by: Anurag Passi, et al.
Published: (2018-05-01)

FIRST LINE ANTI-TUBERCULOSIS DRUG RESISTANCE PATTERN IN MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS PATIENTS CORRELATE WITH ACID FAST BACILLI MICROSCOPY GRADING
by: Soedarsono Soedarsono, et al.
Published: (2020-07-01)

Resistance of anti-tuberculosis drugs among pulmonary tuberculosis patients in Yemen
by: Anwar K. Al-Madhagi, et al.
Published: (2013-07-01)

Glycyrrhiza glabra HPLC fractions: identification of Aldehydo Isoophiopogonone and Liquirtigenin having activity against multidrug resistant bacteria
by: Hazir Rahman, et al.
Published: (2018-05-01)

Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus
by: Yaqian Liu, et al.
Published: (2021-08-01)

Identification of Anti-Persister Activity against Uropathogenic Escherichia coli from a Clinical Drug Library
by: Hongxia Niu, et al.
Published: (2015-05-01)

Bactericidal Activity of Usnic Acid-Chitosan Nanoparticles against Persister Cells of Biofilm-Forming Pathogenic Bacteria
by: Fazlurrahman Khan, et al.
Published: (2020-05-01)

Assessments of serum copper and zinc concentration, and the Cu/Zn ratio determination in patients with multidrug resistant pulmonary tuberculosis (MDR-TB) in Côte d’Ivoire
by: Gnogbo Alexis Bahi, et al.
Published: (2017-04-01)

Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
by: José Miguel Vela
Published: (2020-11-01)

Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria
by: Lucie Peyclit, et al.
Published: (2019-06-01)

Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors
by: Claribel Murillo-Solano, et al.
Published: (2017-07-01)

The journey of antimalarial drugs against SARS-CoV-2: Review article
by: Amany A. Sarhan, et al.
Published: (2021-01-01)

Persistent Mullerian duct syndrome: A case report and review of the literature
by: Odi Temitope, et al.
Published: (2010-01-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
by: Takacs P, et al.
Published: (2019-01-01)

Factors associated with multidrug-resistant tuberculosis
by: Md Nurul Amin, et al.
Published: (2009-01-01)

Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening
by: Ahmed Elkamhawy, et al.
Published: (2021-09-01)

Barriers and Strategies: A Review of Access to Affordable Multi-Drug Resistant Tuberculosis Medication in China
by: Zhang Y, et al.
Published: (2020-10-01)

Persistent organic pollutants and the size of ovarian reserve in reproductive-aged women
by: Richelle D. Björvang, et al.
Published: (2021-10-01)

Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents
by: Li Su, et al.
Published: (2020-11-01)

Design of Potential Anti-Leishmanial Pharmacophores via In Silico Drug Repurposing
by: Sana Ahdeno, et al.
Published: (2020-10-01)

The Deadly Duo of COVID-19 and Cancer!
by: Vivek R. Bora, et al.
Published: (2021-04-01)

Punica granatum peel extracts: HPLC fractionation and LC MS analysis to quest compounds having activity against multidrug resistant bacteria
by: Ilyas Khan, et al.
Published: (2017-05-01)